Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Hormones & Cancer
|
October 27, 2017
Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors
Delphine Vezzosi, Christine Do Cao, Ségolène Hescot, et al.
United European Gastroenterology Journal
|
October 31, 2019
Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)
Caroline Fine, Guillaume Roquin, Eric Terrebonne, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 30, 2017
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
Benjamin Bonhomme, Yann Godbert, Gaelle Perot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 17, 2017
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study
Alain Ravaud, Christelle de la Fouchardière, Philippe Caron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O<sup>6</sup>-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
Thomas Walter, Thierry Lecomte, Julien Hadoux, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 15, 2018
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer
Francoise Borson-Chazot, Emmanuelle Dantony, Frederic Illouz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2013
Is thyroid cancer recurrence risk increased after transplantation?
Hélène Tisset, Nassim Kamar, Isabelle Faugeron, et al.
The Lancet. Oncology
|
October 28, 2017
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
Piero Ferolla, Maria Pia Brizzi, Tim Meyer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 5, 2022
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France
Alexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius, et al.
Annales D'Endocrinologie
|
July 31, 2018
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions
Frédéric Castinetti, Frédéric Albarel, Françoise Archambeaud, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Hormones & Cancer
|
October 27, 2017
Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors
Delphine Vezzosi, Christine Do Cao, Ségolène Hescot, et al.
United European Gastroenterology Journal
|
October 31, 2019
Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)
Caroline Fine, Guillaume Roquin, Eric Terrebonne, et al.
Thyroid : Official Journal of the American Thyroid Association
|
March 30, 2017
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
Benjamin Bonhomme, Yann Godbert, Gaelle Perot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 17, 2017
A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study
Alain Ravaud, Christelle de la Fouchardière, Philippe Caron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O<sup>6</sup>-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
Thomas Walter, Thierry Lecomte, Julien Hadoux, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 15, 2018
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer
Francoise Borson-Chazot, Emmanuelle Dantony, Frederic Illouz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2013
Is thyroid cancer recurrence risk increased after transplantation?
Hélène Tisset, Nassim Kamar, Isabelle Faugeron, et al.
The Lancet. Oncology
|
October 28, 2017
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
Piero Ferolla, Maria Pia Brizzi, Tim Meyer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 5, 2022
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France
Alexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius, et al.
Annales D'Endocrinologie
|
July 31, 2018
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions
Frédéric Castinetti, Frédéric Albarel, Françoise Archambeaud, et al.
Page
of 12